Dr. von Eschenbach steps down from NCI post; Dr. Niederhuber appointed

John Niederhuber, MD, has been designated to serve as acting director of the National Cancer Institute. Andrew von Eschenbach, MD, formally submitted his resignation as NCI director and will continue to serve as acting FDA commissioner.

John Niederhuber, MD, has been designated to serve as acting director of the National Cancer Institute. Andrew von Eschenbach, MD, formally submitted his resignation as NCI director and will continue to serve as acting FDA commissioner.

Dr. Niederhuber joined the National Institutes of Health in 2005 as NCI’s deputy director for translational and clinical sciences. Immediately before his recruitment to NCI, he chaired the National Cancer Advisory Board. His extensive academic and research career in the field of cancer has included positions at the University of Michigan, Johns Hopkins University, Stanford University, and, most recently the University of Wisconsin.

Dr. von Eschenbach, a urologist, was appointed by President Bush to head the NCI in January 2002. He has served as acting FDA commissioner since September 2005.

Related Videos
Doctor receiving patient in office | Image Credit © Africa Studio - stock.adobe.com
Alisa J. Stephens-Shields, PhD, answers a question during a Zoom video interview
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Dr. David Sheyn in an interview with Urology Times
Avinash Maganty, MD, answers a question during a Zoom video interview
blur image background of corridor in hospital or clinic image | Image Credit:  © whyframeshot - stock.adobe.com
Rachel Pope, MD, MPH, answers a question during a Zoom interview
blur image background of corridor in hospital or clinic image | Image credit: © whyframeshot - stock.adobe.com
Dr. David Canes in an interview with Urology Times
Urinary bladder | Image credit: © magicmine - stock.adobe.com
Related Content
© 2023 MJH Life Sciences

All rights reserved.